Salicylic acid has spent two decades as a quiet workhorse of consumer skincare, and in 2026 it has quietly become a sourcing decision again. BHA-based serums sit at the intersection of three durable signals: routine-driven K-beauty habits, year-round demand from blemish-prone consumers, and a fourth quarter when industry surveys explicitly name skincare as a category that spikes around the holidays. For a private label brand, the question is no longer whether BHA still sells. The question is which format, which concentration band, and which seasonal window your stock should hit — and how to source it without overcommitting inventory to a trend you have not verified in your own market.
Salicylic acid belongs to the beta hydroxy acid (BHA) family. Unlike water-soluble AHAs that work mostly on the skin surface, salicylic acid is oil-soluble, which is why it is commonly used in products designed to address pores and blemish-prone skin. The American Academy of Dermatology lists salicylic acid among the exfoliating ingredients consumers can look for in over-the-counter acne-friendly products, and the AAD’s acne resource center treats it as one of the standard options dermatologists reference.
That durability is exactly what makes BHA interesting for a 2026 private label line. Trending actives come and go — jelly textures, viral peptides, novel delivery formats — but a core exfoliant that consumers already understand converts faster. Buyers do not need to be educated on what it is; they need a version of it in the format, texture, and price point that fits their brand.
The 2026 context adds two supporting winds. First, routine complexity has normalized multi-active regimens: many consumers now rotate a BHA night with a hydration-focused morning, which keeps BHA inside the routine even when a new star ingredient takes the spotlight. Lanthome has tracked a related pattern with other actives — see the PDRN balm stick OEM line decisions page for how a newer K-beauty ingredient layers on top of a stable routine core. Second, “fewer, better actives” positioning has pushed brands toward single-active serums with clean labeling, which is precisely the format a contract manufacturer can produce at tight MOQs.
A serum is also the highest-leverage BHA format for a first entry. A 30ml leave-on serum is a standard shelf size, a standard price point, and a standard review surface — the easiest format to test, extend, and defend in a lineup.
Trend talk is cheap; a sourcing decision should rest on signals you can reproduce yourself. Here is a practical checklist we use with brand partners before they commit to a BHA line.
Search-intent snapshot. Run the phrases “BHA serum,” “salicylic acid serum,” and “salicylic acid for [your market’s language]” through your market’s search engine over a 30-day window. You are not chasing absolute numbers — you are checking direction and the questions that cluster around them (sticky texture, sensitive skin, layering with retinol, pregnancy safety). The questions tell you where your label copy and FAQ content should land.
Autocomplete and related searches. The long-tail suggestions are the real demand map. If your market’s autocomplete surfaces “salicylic acid for dark spots” or “BHA for oily skin,” your hero benefit should mirror that pairing rather than a generic exfoliation claim.
Marketplace SKU density. Count how many active BHA serums a competing marketplace lists in your price band, and skim the one- and two-star review themes of the top sellers. Complaints are your product brief: if texture stickiness dominates negative reviews, an alcohol-free, fast-absorbing base is your differentiation. If packaging leaks, an airless or dropper upgrade is your story.
Channel behavior data. PwC’s Holiday Outlook 2026 survey of 4,093 US consumers (fielded June 2026) shows 29% planning to use AI somewhere in their holiday shopping, up from 22% the prior year, with most of that usage going to product research. It also finds 52% expecting to visit physical stores in person, ahead of search engines at 42% and social media at 29%. The implication for a BHA brand: consumers discover through social and AI-assisted research, then convert wherever trust closes. Clean, factual product pages and label claims survive both the algorithm and the store shelf.
Adjacent-trend cross-check. BHA rarely trends alone in K-beauty; it pairs with centella, niacinamide, and hydration actives. If those companions are already moving in your market, a BHA + hydration hybrid (covered next) is a lower-risk second SKU than a standalone BHA toner.
None of this requires market-research software. A spreadsheet, thirty minutes, and your market’s own search behavior will tell you whether the trend is real for you before a single container is filled.
Not every BHA product is a serum. Format is where differentiation happens, and it is also where your sourcing MOQs change. The four formats we see brand partners request most often:
| Format | Routine role | Sourcing notes |
|---|---|---|
| Leave-on serum (30ml) | Night exfoliation, pore-focused | Core SKU; standard size; easiest to extend into a line |
| Pads / towelettes | One-step application, travel | Higher per-unit component count; gifting-friendly in Q4 |
| BHA + hydration hybrid | Winter pairing, sensitive-skin entry | Positions BHA as gentle; pairs well with centella or niacinamide |
| BHA toner (K-style) | Morning or post-cleansing step | Competitive space; wins on texture and labeling clarity |
The reference product for this guide, a 30ml private label salicylic acid serum, sits in the first row: a leave-on essence designed for blemish-prone skin, with herbal positioning and an organic OEM framing. It is the format we most often recommend for a first BHA launch, because the 30ml bottle carries the lowest per-unit complexity while leaving room to grow a line.
Concentration bands. Consumer leave-on BHAs are commonly formulated in the 0.5%–2% range, with lower bands targeting sensitive-skin introductions and higher bands targeting established exfoliation routines. Every concentration is subject to formulation, stability, and patch-evaluation work, and to the rules of your destination market — the Cosmetic Ingredient Review’s ingredient safety resources are a good neutral starting point for what has been assessed, while the US regulatory picture is covered in the guardrails section below. Do not treat a higher percentage as a better product; a 2% BHA in a poorly buffered base underperforms a well-made 1% formula.
Texture is a trend, not a footnote. The reviews on best-selling BHAs read like texture surveys. Alcohol-free, fast-absorbing, non-sticky bases are the current consumer expectation, and they are also a formulation conversation to have with your manufacturer early — texture choices affect viscosity, preservative system, and cost.
Pairing logic sells the line. The strongest BHA listings in 2026 are not selling “exfoliation”; they are selling a step in a routine. A BHA serum paired with a hydrating moisturizer or a centella-toned repair cream (see our broader face care collection for companion formats) creates a natural second SKU and a higher average order value.
BHA is often described as a “summer” active, and in routine logic that is fair — warmth drives oil, and exfoliation sells. But the revenue logic of Q4 is different, and it is the quarter where skincare brands make their year.
PwC’s Holiday Outlook 2026 is explicit on the seasonal point: it names skincare alongside apparel and food and beverage as one of the categories that spikes around the holidays, and it notes that in those categories, a stockout is not a missed sale — it is “permission to skip the purchase altogether.” The same survey reports US holiday gift spending projected to dip only 2% year over year even as consumer confidence fell sharply, with an average of $708 expected per person ($875 in households with children). Roughly 40% of all planned gift spending lands in the five-day window from Thanksgiving through Cyber Monday, 79% of consumers say deals influence when they shop, and beauty appears among the top five gifts for adult family and friends.
What that means for a BHA line:
There is a quieter Q4 tailwind as well. The same PwC data shows 29% of consumers using AI to research holiday products, with Gen Z the heaviest users (73% of Gen Z AI users turn to it to explore gift ideas). Consumers increasingly ask AI assistants “what should I give someone with oily skin?” A product page with clear, factual, well-structured answers about what the serum is, who it is for, and how it is made is now a sales channel in its own right. You can read more of Lanthome’s buyer-oriented analysis in the Insights hub.
BHA sits on a regulatory boundary that trips up more private label brands than any formulation question. Get this wrong and a trending product becomes an enforcement risk.
The US cosmetics/drugs line. In the United States, a product that claims to treat or prevent disease — including claims that it “treats acne” — is regulated as a drug, not a cosmetic. Salicylic acid is an approved OTC active for acne under the monograph system, which means OTC acne products containing it operate under drug rules, with their own labeling and facility requirements. A cosmetic BHA product should be positioned for its cosmetic role: exfoliation, pore appearance, smooth texture, suitability for blemish-prone skin. The FDA’s cosmetics resources set out the company responsibility for cosmetic safety and the claims boundary. In short: the same molecule can be sold on two completely different legal tracks, and your label language decides which one you are on.
Ingredient safety assessment. The Cosmetic Ingredient Review (CIR) expert panel has assessed salicylic acid as used in cosmetics, and its safety assessment resources are a useful neutral reference when you brief your label and your regulator conversations. “Assessed” is not “guaranteed” — formulation, concentration, and use pattern all matter — but a documented safety-review trail is part of a professional file.
Dermatologist context, used honestly. The American Academy of Dermatology describes salicylic acid as a common over-the-counter option for acne-prone skin in consumer education. That makes it a credible, quotable context for your marketing — provided your own claims stay on the cosmetic side of the line described above.
Destination-market limits. Outside the US, salicylic acid appears in restricted-substance lists with concentration ceilings for leave-on and rinse-off products. The EU Cosmetics Regulation, Regulation (EC) No 1223/2009, is the standard reference for European markets. Confirm the exact permitted level for your formulation and product type before the formula is locked — this is a one-page check that should never be a post-production discovery.
Labeling fundamentals. Regardless of market: INCI name on the ingredient list, the active percentage where your market requires it, a directions-of-use line that matches the real frequency (for example, “use once or twice weekly, then increase as tolerance allows”), and a patch-test note for sensitive skin. Conservative, accurate labeling is also what makes your product page survive the AI-research channel described above.
Trend analysis only becomes revenue when the supply side is structured for it. Here is the fact base for the reference product — the private label 30ml salicylic acid serum — as published on its product page:
| Format | 30ml leave-on serum / essence |
| Shelf life | 3 years |
| Sample MOQ | 1 piece |
| In-stock MOQ | 100 pieces |
| Custom MOQ | 500–1,000 pieces (per custom process) |
| Special-process MOQ | 3,000 pieces |
| Certifications listed | ISO 22716 / GMP / BSCI / SGS / Intertek / CE / COA / MSDS |
| Delivery (in stock) | Under 7 days |
| Production time (custom) | 9–21 working days after payment |
| Payment terms | T/T, PayPal, Western Union, bank transfer, Alibaba Trade Assurance |
| Services | One-stop OEM/ODM/OBM, sampling, rapid proofing, free design, marketing materials, pre- and post-sale tracking |
The MOQ ladder is the part most trend buyers underuse. Read it as a three-stage de-risking path:
Stage 1 — Sample (1 piece). Before any production decision, receive the sample and run it against your market’s expectations: texture, absorption, scent profile, bottle feel. A single piece costs less than one ad dollar wasted on a texture your audience will review negatively.
Stage 2 — In-stock (100 pieces, ships under 7 days). This is your trend-validation run and your Q4 safety valve. One hundred units is enough to test marketplace listings, run a soft launch, seed content, and collect real review data — with delivery fast enough to catch late-quarter demand.
Stage 3 — Custom (500–1,000 pieces, 9–21 working days). Once the in-stock run has earned its keep, move to your own formula adjustment, label, and packaging. The custom MOQ sits where a validated trend becomes a brand asset. Special processes — airless packaging, hybrid actives, granules — move to the 3,000-piece tier, and the decision should be made on forecast data from stages 1 and 2, not on intuition.
The production numbers also map directly onto the seasonal calendar from the positioning section: a September custom order with 9–21 working days of production lands in time for a late-October listing, which is exactly when Q4 search intent starts climbing. For the commercial mechanics of working with a manufacturer like this — including the About Us page for facility and capability context — the Contact Us page is the fastest route to a quotation and a sample.
Is BHA still trending in 2026, or is it a passing fad?
BHA behaves less like a fad and more like routine infrastructure. The novel actives of 2026 layer on top of exfoliation, but salicylic acid remains one of the ingredients dermatologists and consumer surveys still point to for blemish-prone skin. The trend question for you is format and positioning, not relevance.
What concentration should my first BHA serum use?
Consumer leave-on BHAs are commonly found between 0.5% and 2%. A lower band (around 0.5–1%) suits a sensitive-skin or introduction positioning; the higher end suits an established exfoliation routine. Whichever you choose, confirm the destination-market limit for your product type before locking the formula, and build tolerance guidance into the directions of use.
Can I still launch a BHA serum in time for Q4?
For in-stock formats, yes — an in-stock 30ml serum with under-7-day delivery can reach the shelf for the final stretch. For a fully custom formula and package, September is the realistic decision month given 9–21 working days of production plus logistics and listing time.
What is the difference between a BHA serum and an OTC acne treatment in the US?
Claims. A cosmetic BHA product is positioned for exfoliation, texture, and pore appearance. A product claiming to treat acne is regulated as an OTC drug, and salicylic acid is an approved OTC acne active under the US monograph system. The same ingredient, two different regulatory tracks — your label language chooses the track.
How do MOQs work for testing a trend before committing?
The reference product supports a 1-piece sample, a 100-piece in-stock run, and 500–1,000 pieces for customization. That ladder lets you validate the trend with market data at each stage instead of betting the full production run on a forecast.
Can a BHA formula be combined with other trending actives?
Yes — BHA + hydration hybrids (centella, niacinamide, panthenol-type support) are among the most requested winter formulations. Compatibility is a formulation question: actives, pH, and stability all need to be evaluated in the final formula, which is exactly what the sampling stage exists for.
About the Author
This article was prepared by the Lanthome skincare manufacturing team, with experience in private label formulation, packaging development, quality control, and international OEM/ODM projects.
